• 1. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 2. An ion-gating multinanochannel system based on a copper-responsive self-cleaving DNAzyme?
  Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023
• 3. An investigation on the interaction modes of a single-strand DNA aptamer and RBP4 protein: a molecular dynamic simulations approach?
  Raheleh Torabi,Hedayatollah Ghourchian,Massoud Amanlou Org. Biomol. Chem., 2016,14, 8141-8153
• 4. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 5. Achieving excellent anti-corrosion and tribological performance by tailoring the surface morphology and chemical composition of aluminum alloys
  Wenjie Zhao,Hua Hou,Yuchun Jin,Zhixiang Zeng,Xuedong Wu,Qunji Xue RSC Adv., 2014,4, 60307-60315

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines Pyrrolopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines
• Solvents and Organic Chemicals Organic Compounds Organic Halides

Introduction to 6-Chloro-1H-pyrrolo[3,2-b]pyridine (CAS No. 1021339-19-4)

6-Chloro-1H-pyrrolo[3,2-b]pyridine, identified by the Chemical Abstracts Service Number (CAS No.) 1021339-19-4, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical and medicinal chemistry. This bicyclic structure, featuring a pyrrole ring fused with a pyridine ring, is characterized by the presence of a chlorine substituent at the 6-position. The unique combination of these structural elements imparts distinct chemical and biological properties, making it a valuable scaffold for the development of novel therapeutic agents.

The 6-Chloro-1H-pyrrolo[3,2-b]pyridine scaffold has been extensively explored in recent years due to its potential as a building block for drugs targeting various diseases. Its molecular framework allows for modifications at multiple positions, enabling chemists to tailor its pharmacological properties for specific applications. The chlorine atom at the 6-position not only influences the electronic distribution of the molecule but also serves as a handle for further functionalization, facilitating the synthesis of more complex derivatives.

In the realm of drug discovery, 6-Chloro-1H-pyrrolo[3,2-b]pyridine has been investigated for its role in modulating biological pathways associated with inflammation, cancer, and neurodegenerative disorders. Recent studies have highlighted its potential in inhibiting key enzymes and receptors involved in these conditions. For instance, derivatives of this compound have shown promise in preclinical trials as inhibitors of Janus kinases (JAKs), which play a crucial role in signal transduction pathways relevant to autoimmune diseases.

The synthesis of 6-Chloro-1H-pyrrolo[3,2-b]pyridine involves multi-step organic reactions that typically begin with readily available precursors. One common synthetic route involves the cyclization of 2-aminoethylidine with appropriate pyrrole derivatives followed by chlorination. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making this compound more accessible for research and development purposes. The ability to produce high-purity 6-Chloro-1H-pyrrolo[3,2-b]pyridine is essential for ensuring the reliability of downstream applications, particularly in medicinal chemistry.

The biological activity of 6-Chloro-1H-pyrrolo[3,2-b]pyridine is largely influenced by its ability to interact with biological targets such as enzymes and receptors. The chlorine substituent enhances electrophilicity at the 6-position, allowing for nucleophilic substitution reactions that can be exploited to create bioactive molecules. Additionally, the aromatic nature of the pyrrole and pyridine rings contributes to favorable interactions with binding pockets in biological targets, improving binding affinity and selectivity.

Recent research has also explored the pharmacokinetic properties of 6-Chloro-1H-pyrrolo[3,2-b]pyridine derivatives. Understanding how these compounds are absorbed, distributed, metabolized, and excreted (ADME) is critical for optimizing their therapeutic potential. Studies have shown that modifications to the molecular structure can significantly impact these properties, influencing both efficacy and safety profiles. For example, incorporating hydrophilic groups can enhance solubility and bioavailability, while lipophilic substitutions may improve membrane permeability.

The therapeutic applications of 6-Chloro-1H-pyrrolo[3,2-b]pyridine are diverse and span multiple disease areas. In oncology, derivatives of this compound have demonstrated preclinical activity against various cancer types by inhibiting key signaling pathways involved in tumor growth and progression. Additionally, its potential in treating inflammatory diseases has been recognized due to its ability to modulate cytokine production and immune responses.

In conclusion,6-Chloro-1H-pyrrolo[3,2-b]pyridine (CAS No. 1021339-19-4) represents a promising scaffold for drug development with significant potential in addressing various therapeutic challenges. Its unique structural features and versatile reactivity make it an attractive candidate for further exploration in medicinal chemistry. As research continues to uncover new biological targets and synthetic strategies,6-Chloro-1H-pyrrolo[3,2-b]pyridine derivatives are likely to play an increasingly important role in the discovery and development of novel therapeutics.

• 67967-10-6(5-chloro-1,7-Naphthyridine)
• 35170-89-9(3-chloro-1,7-Naphthyridine)
• 1310693-43-6(6-chloro-5H-Pyrido[3,2-b]indole)
• 28252-80-4(4,8-Dichloro-1,5-naphthyridine)
• 1071196-62-7(9-chloro-1H-Pyrrolo[3,2-b]quinoline)
• 1188313-15-6(4-Chloro-1H-pyrrolo[2,3-c]pyridine)
• 1000342-65-3(3-Chloro-5-azaindole)
• 929074-47-5(8-chloropyrido[3,4-b]pyrazine)
• 357263-48-0(7-Chloro-1H-pyrrolo[3,2-B]pyridine)
• 7689-63-6(4-Chloro-1,5-naphthyridine)